Regulation of mevalonate metabolism in cancer and immune cells

Martin Thurnher1, Georg Gruenbacher, Oliver Nussbaumer

  • 1Department of Urology, Innsbruck Medical University, Austria. martin.thurnher@i-med.ac.at

Insights

Targeting the mevalonate pathway offers a dual approach to cancer therapy. Modulating this pathway impacts tumor cell growth and enhances immune surveillance for improved cancer treatment.

Area of Science:

  • Biochemistry
  • Metabolic pathways
  • Cancer biology

Background:

  • The mevalonate pathway is essential for producing isoprenoids like cholesterol and prenyl pyrophosphates.
  • These isoprenoids are crucial for protein prenylation, particularly for Ras superfamily proteins involved in cancer.
  • The pathway is often overactive in cancer cells, making it a significant therapeutic target.

Purpose of the Study:

  • To review the effects of pharmacologic regulation of the mevalonate pathway in cancer.
  • To explore how this regulation impacts both cancer cells and immune cells.
  • To understand the combined contribution to cancer therapy efficacy.

Main Methods:

  • Literature review of studies on mevalonate pathway pharmacologic regulation.
  • Analysis of effects on cancer cell proliferation, survival, invasion, and metastasis.
  • Evaluation of impacts on immune cells and cancer immune surveillance.

Main Results:

  • Pharmacologic interventions can alter mevalonate pathway intermediates, leading to upstream accumulation and downstream depletion.
  • These alterations have differential effects on cancer cells versus immune cells.
  • Mevalonate pathway regulation can directly affect tumor biology and indirectly boost anti-tumor immunity.

Conclusions:

  • Modulating the mevalonate pathway presents a promising strategy for cancer therapy.
  • The pathway's regulation influences tumor progression and immune response.
  • Combined effects on cancer and immune cells may enhance overall therapeutic outcomes.

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...